FFCP PHASE1:Hg19::chr12:125478241..125478260,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p2@BRI3BP |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_BRI3BP_5end |
Coexpression cluster: | C3251_granulocyte_Burkitt_acute_signet_diffuse_splenic_biphenotypic |
Association with transcript: | 0bp_to_ENST00000341446_5end |
EntrezGene: | BRI3BP |
HGNC: | 14251 |
UniProt: | Q8WY22 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@BRI3BP |
---|
0
10
20
30
40
50
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 2.55e-32 | 235 |
disease of cellular proliferation | 3.21e-31 | 239 |
hematologic cancer | 9.79e-21 | 51 |
immune system cancer | 9.79e-21 | 51 |
carcinoma | 1.32e-19 | 106 |
cell type cancer | 1.59e-17 | 143 |
organ system cancer | 4.82e-17 | 137 |
leukemia | 4.34e-16 | 39 |
myeloid leukemia | 2.43e-12 | 31 |
lymphoma | 7.07e-07 | 10 |
Showing 1 to 10 of 10 entries